37 episodes

Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer

Talking About Tumors with Ryann and Ryan - A medical oncology podcast Talking About Tumors

    • Education
    • 5.0 • 2 Ratings

Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer

    03_13 Head and Neck Cancer – Locally advanced and metastatic

    03_13 Head and Neck Cancer – Locally advanced and metastatic

     
    Role for definitive chemotherapy and radiationControversy on induction chemotherapyConsiderations for nasopharyngeal cancerApproach to metastatic HNSCCCitations
    As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com.  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
    DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
    Uptodate.com Waltham, MA: Wolters Kluwer.
    1.           Burtness B et al. J Clin Oncol. 2022;40(21):2321-2332. doi:10.1200/JCO.21.02198
    2.           Burtness B et al. Lancet. 2019;394(10212):1915-1928. doi:10.1016/S0140-6736(19)32591-7
    3.           Vermorken JB et al. NEJM 2008;359(11):1116-1127. doi:10.1056/NEJMOA0802656
    4.           Gibson MK et al. JCO. 2005;23(15):3562-3567. doi:10.1200/JCO.2005.01.057
    5.           Zhang L et al. Lancet. 2016;388(10054):1883-1892. doi:10.1016/S0140-6736(16)31388-5
    6.           Zhang Y et al. NEJM. 2019;381(12):1124-1135. doi:10.1056/NEJMOA1905287
    7.           Gau M et al. Oral Oncol. 2019;95:164-169. doi:10.1016/J.ORALONCOLOGY.2019.06.015
    8.           GT W, et al. NEJM. 1991;324(24):1685-1690. doi:10.1056/NEJM199106133242402
    9.           Lacas B et al. Radiother Oncol. 2021;156:281. doi:10.1016/J.RADONC.2021.01.013
    10.        Bourhis  et al. JCO. 2004;22(14_suppl):5505-5505. doi:10.1200/JCO.2004.22.90140.5505
    11.        Gyawali B et al. Cancer Treat Rev. 2016;44:10-16. doi:10.1016/J.CTRV.2016.01.002
    12.        Forastiere AA et al. J Clin Oncol. 1992;10(8):1245-1251. doi:10.1200/JCO.1992.10.8.1245
    13.        Posner MR et al. NEJM. 2007;357(17):1705-1715. doi:10.1056/NEJMOA070956/
     
    Disclosures
    Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 
    Tags
    Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
     

    • 37 min
    03_12 Head and Neck Cancer – Background and adjuvant considerations

    03_12 Head and Neck Cancer – Background and adjuvant considerations

    Anatomy, diagnostic work-up and stagingField cancerizationIndications for adjuvant concurrent chemoradiationEvidence to support weekly cisplatin with concurrent radiation

    Citations
    As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com.  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
    DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
    Uptodate.com Waltham, MA: Wolters Kluwer.
    1.           Bernier J et al. Head Neck. 2005;27(10):843-850. doi:10.1002/HED.20279
    2.           Zevallos JP et al. Head Neck. 2021;43(1):108. doi:10.1002/HED.26465
    3.           Young A, Okuyemi OT. StatPearls. Published online January 12, 2023. Accessed October 30, 2023. https://www.ncbi.nlm.nih.gov/books/NBK563022/
    4.           Kiyota N et al.  J Clin Oncol. 2022;40(18):1980-1990. doi:10.1200/JCO.21.01293
    5.           Sharma P et al. J Clin Oncol. 2022;40(16). doi: 10.1200/JCO.2022.40.16_suppl.6004
    6.           Cooper JS et al. NEJM. 2004;350(19):1937-1944. doi:10.1056/NEJMOA032646
    7.           Bernier J et al. NEJM. 2004;350(19):1945-1952. doi:10.1056/NEJMOA032641
     
    Disclosures
    Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 
    Tags
    Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
     

    • 23 min
    03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma

    03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma

     
    Presentation, and considerations for regional mesotheliomaSystemic therapy options for advanced mesotheliomaCorticosteroids for pemetrexed, paclitaxel and docetaxelA quick review on considerations for LCNEC Citations
    As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com.  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
    DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
    Uptodate.com Waltham, MA: Wolters Kluwer.


    1.           Peters S et al. Ann Oncol. 2022;33(5):488-499. doi:10.1016/j.annonc.2022.01.074
    2.           Baas P et al. Lancet. 2021;397(10272):375-386. doi:10.1016/S0140-6736(20)32714-8
    3.           Vogelzang NJ et al. J Clin Oncol. 2003;21(14):2636-2644. doi:10.1200/JCO.2003.11.136
    4.           Zalcman G, et al. Lancet. 2016;387(10026):1405-1414. doi:10.1016/S0140-6736(15)01238-6
    5.           Santoro A, et al. J Thorac Oncol. 2008;3(7):756-763. doi:10.1097/JTO.0B013E31817C73D6
    6.           Lindsay CR et al. Br J Cancer 2021;125(9):1210-1216. doi:10.1038/s41416-021-01407-9
     
    Disclosures
    Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 
    Tags
    Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
     

    • 29 min
    03_10 Small cell lung cancer

    03_10 Small cell lung cancer

    Background on SCLCApproach to treatment by stageEmerging discussion on prophylactic cranial irradiationBrief review of basket and umbrella trialsCitations
    As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com.  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
    DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
    Uptodate.com Waltham, MA: Wolters Kluwer.
    1.           Trigo J et al. Lancet Oncol. 2020;21(5):645-654. doi:10.1016/S1470-2045(20)30068-1
    2.           O’Brien MER et al. J Clin Oncol. 2006;24(34):5441-5447. doi:10.1200/JCO.2006.06.5821
    3.           Rudin CM et al. J Clin Oncol. 2020;38(21):2369-2379. doi:10.1200/JCO.20.00793
    4.           Paz-Ares L et al. The Lancet. 2019;394(10212):1929-1939. doi:10.1016/S0140-6736(19)32222-6
    5.           Horn L et al NEJM. 2018;379(23):2220-2229. doi:10.1056/NEJMOA1809064/
    6.           Lowenbraun S et al. Cancer. 1979;44:406-413. doi:10.1002/1097-0142
    7.           Hochstenbag M et al.. J Neurooncol. 2000;48(3):243-248. doi:10.1023/A:1006427407281
    8.           Meert AP et al. BMC Cancer. 2001;1(1):1-9. doi:10.1186/1471-2407-1-5/TABLES/4
    9.           Fried DB et al.  J Clin Oncol. 2004;22(23):4785-4793. doi:10.1200/JCO.2004.01.178
    10.        Pignon JP et al. 2010;327(23):1618-1624. doi:10.1056/NEJM199212033272302
    11.        Warde P, Payne D.   J Clin Oncol. 1992;10(6):890-895. doi:10.1200/JCO.1992.10.6.890
    12.        Wong AT et al. J Thorac Oncol. 2016;11(2):242-248. doi:10.1016/J.JTHO.2015.10.011
    13.        Lu C  et al. Ther Innov Regul Sci. 2021;55(6):1145. doi:10.1007/S43441-021-00315-7
     
    Disclosures
    Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 
    Tags
    Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology

    • 33 min
    03_09 Stage III NSCLC for the Medical Oncologist

    03_09 Stage III NSCLC for the Medical Oncologist

    Refresher on T+N staging for Stage IIIEvidence for concurrent chemoradiationPACIFIC TrialEncourage cessation regardless of stage of Lung Cancer 
    Citations
    As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com.  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
    DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
    Uptodate.com Waltham, MA: Wolters Kluwer.


    1.           Ajani JA et al.. Ann Oncol. 2013;24(11):2844-2849. doi:10.1093/ANNONC/MDT339
    2.           Curran WJ et al. J Natl Cancer Inst. 2011;103(19):1452-1460. doi:10.1093/JNCI/DJR325
    3.           Vokes EE, et al. JCO. 2007;25(13):1698-1704. doi:10.1200/JCO.2006.07.3569
    4.           Dillman RO et al. NEJM. 1990;323(14):940-945. doi:10.1056/NEJM199010043231403
    5.           Daly ME et al. JCO. 2022;40(12):1356-1384. doi:10.1200/JCO.21.02528
    6.           Spigel DR et al. JCO. 2022;40(12):1301-1311. doi:10.1200/JCO.21.01308
    7.           Antonia SJ et al. NEJM. 2017;377(20):1919-1929. doi:10.1056/NEJMOA1709937
    8.           Senan et al. JCO. 2016;34(9):953-962. doi:10.1200/JCO.2015.64.8824
     
     
     
    Disclosures
    Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 
    Tags
    Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology

    • 27 min
    03_08 ADAURA Trial

    03_08 ADAURA Trial

    Background on adjuvant EGFR therapy
    Discussion of initial and updated results
    Hazard Ratios and Context
    When crossover and access limit generalizability


    Citations
    As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com.  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
    DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
    Uptodate.com Waltham, MA: Wolters Kluwer.

    1.Herbst et al. JCO.  2023;41(10):1830-1840. doi: 10.1200/JCO.22.02186
    2.Wu et al. NEJM. 2023;383:1711-1723. doi:10.1056/NEJMoa2027071
    3.       Tsuboi et al. NEJM. 2023;389(2):137-147. doi: 10.1056/NEJMoa2304594
    4. West and Gyawali. JAMA Oncol. 2021;7(5):677-678. doi:10.1001/jamaoncol.2020.6752
    5. Gyawali and West. JCO. 2021;39(3):175-177. doi: 10.1200/JCO.20.01762
    6. Prasad. Plenary Session.  “ADAURA OS Results”. Podcast episode published June 8, 2023 
    7. Haslan and Prasad. Ann Oncol. 2018; 29(5):1079–1081. doi: 10.1093/annonc/mdy116
    8. Tannock et al. JCO.  2023;41(15):2713-2717 doi: 10.1200/JCO.23.00280


     
    Disclosures
    Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 

    Tags
    Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology

    • 25 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Education

Mel Robbins
CAKE MEDIA
Dr. Jordan B. Peterson
Mark Manson
Black Girl Flow Podcast
The Atlantic

You Might Also Like